A detailed history of Royal Bank Of Canada transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Royal Bank Of Canada holds 3,009 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,009
Previous 2,004 50.15%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
1,005 Added 50.15%
3,009 $0
Q2 2024

Aug 14, 2024

SELL
N/A
-124,996 Reduced 98.42%
2,004 $0
Q1 2024

Nov 05, 2024

BUY
N/A
124,996 Added 6237.33%
127,000 $0
Q1 2024

May 15, 2024

BUY
N/A
21,093 Added 19.92%
127,000 $0
Q4 2023

Feb 14, 2024

SELL
N/A
-17,685 Reduced 14.31%
105,907 $0
Q3 2023

Nov 14, 2023

SELL
N/A
-23,409 Reduced 15.92%
123,592 $0
Q2 2023

Aug 14, 2023

SELL
N/A
-1,466 Reduced 0.99%
147,001 $0
Q1 2023

May 15, 2023

SELL
N/A
-2,228 Reduced 1.48%
148,467 $0
Q4 2022

Feb 14, 2023

BUY
$0.0 - $9.95 $0 - $33,591
3,376 Added 2.29%
150,695 $0
Q3 2022

Nov 14, 2022

BUY
$8.57 - $11.57 $1,456 - $1,966
170 Added 0.12%
147,319 $1.31 Million
Q2 2022

Aug 15, 2022

BUY
$8.84 - $11.64 $385,786 - $507,981
43,641 Added 42.16%
147,149 $1.47 Million
Q1 2022

May 16, 2022

SELL
$10.07 - $11.93 $38,406 - $45,501
-3,814 Reduced 3.55%
103,508 $1.2 Million
Q4 2021

Feb 14, 2022

BUY
$7.95 - $11.24 $18,014 - $25,469
2,266 Added 2.16%
107,322 $1.19 Million
Q3 2021

Nov 15, 2021

BUY
$9.22 - $12.44 $128,655 - $173,587
13,954 Added 15.32%
105,056 $969,000
Q2 2021

Aug 16, 2021

BUY
$9.91 - $12.78 $902,820 - $1.16 Million
91,102 New
91,102 $1.03 Million

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.